FLT1 and preeclampsia: The cardiovascular and renal risks in preeclampsia patients might be due to thepresence of anti-angiogenic factors, like the soluble vascular endothelial growthfactor receptor 1 (sVEGFR-1) also known as soluble fms-like tyrosine kinase 1(sFlt1).